CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 138 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,601,199 | +30.1% | 277,515 | -63.8% | 0.01% | +40.0% |
| Q1 2021 | $3,536,000 | -42.0% | 767,041 | -58.0% | 0.01% | +25.0% |
| Q4 2020 | $6,096,000 | +94.5% | 1,825,054 | +77.6% | 0.00% | -20.0% |
| Q3 2020 | $3,134,000 | -58.9% | 1,027,387 | -37.8% | 0.01% | -64.3% |
| Q2 2020 | $7,634,000 | +46.6% | 1,652,211 | +24.4% | 0.01% | +27.3% |
| Q1 2020 | $5,208,000 | +292.8% | 1,328,566 | +275.6% | 0.01% | +450.0% |
| Q4 2019 | $1,326,000 | – | 353,757 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 589,883 | $590,000 | 1.38% |
| Broadfin Capital, LLC | 8,200,000 | $8,610,000 | 0.96% |
| Avoro Capital Advisors LLC | 1,141,149 | $1,198,000 | 0.24% |
| CORRADO ADVISORS, LLC | 190,600 | $200,000 | 0.12% |
| Baker Brothers Advisors | 5,102,153 | $5,357,000 | 0.05% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 756,311 | $794,000 | 0.04% |
| Point72 Asset Management, L.P. | 2,272,816 | $2,386,000 | 0.02% |
| AGRAN LIBBIE | 44,000 | $46,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 10,000 | $11,000 | 0.01% |
| KENNEDY CAPITAL MANAGEMENT LLC | 233,171 | $245,000 | 0.00% |